IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)
-
01/12/2024, 07:04
-
ansa.it
0
Scopri altro
- oggi, 19:35
-
repubblica.it
-
1
- 31/01/2025, 07:04
-
ansa.it
-
0
- 31/01/2025, 07:04
-
ansa.it
-
0
- 31/01/2025, 06:13
-
ansa.it
-
0
- 31/01/2025, 01:53
-
ansa.it
-
0
- 31/01/2025, 00:28
-
ansa.it
-
0
- 31/01/2025, 00:28
-
ansa.it
-
0
- 31/01/2025, 00:04
-
ansa.it
-
0
Nessun commento